Psilocybin reduces symptoms of major depression: The Lancet

Published Date: 04 Mar 2023

A new study by Robin von Rotz and his team found that moderate doses of psilocybin for at least two weeks reduced symptoms of depression...

Read Full News

Latest News

WHO Confirms 18 Attacks on Healthcare Sites in Iran

The World Health Organization said on Wednesday that it has verified 18 attacks on healthcare centers ⁠in Iran since the start of the U.S. and Israel war on Iran.

How Can First-Year Residents Avoid Clinical Errors?

Experts say that many early residency mistakes stem from structural factors such as workload, supervision, and training environment, rather than from individual performance.

Dry Powder Inhaler May Reduce COPD Exacerbations

In patients with COPD, starting the umeclidinium-vilanterol dry powder inhaler may lower the risk for exacerbations compared with starting glycopyrrolate-formoterol or tiotropium-olodaterol inhalers.

Add-On Vancomycin Taper May Reduce C difficile Recurrence

In patients with a first episode or first recurrence of Clostridioides difficile infection, adding a vancomycin taper after the standard 14-day course may delay or lower the risk for recurrence.

Donna Ockenden to Lead Review of Leeds Maternity Failures

An independent review will examine maternity and neonatal services at Leeds Teaching Hospitals after repeated safety failures.

Tylenol Use Among Women Dropped After Trump Tied It to Autism, Lancet Analysis Shows

Tylenol use among pregnant women fell after U.S. President Donald Trump linked autism to the over-the-counter pain relief medicine, according to an analysis of U.S....

Todays Updates

Chemoimmunotherapy Boosts Head and Neck Cancer Response

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

Todays Updates

Chemoimmunotherapy Boosts Head and Neck Cancer Response

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

Latest News

The World Health Organization said on Wednesday that it has verified 18 attacks on healthcare centers ⁠in Iran since the start of the U.S. and Israel war on Iran.

Experts say that many early residency mistakes stem from structural factors such as workload, supervision, and training environment, rather than from individual performance.

In patients with COPD, starting the umeclidinium-vilanterol dry powder inhaler may lower the risk for exacerbations compared with starting glycopyrrolate-formoterol or tiotropium-olodaterol inhalers.

In patients with a first episode or first recurrence of Clostridioides difficile infection, adding a vancomycin taper after the standard 14-day course may delay or lower the risk for recurrence.

An independent review will examine maternity and neonatal services at Leeds Teaching Hospitals after repeated safety failures.

Tylenol use among pregnant women fell after U.S. President Donald Trump linked autism to the over-the-counter pain relief medicine, according to an analysis of U.S....

News All Time

Australia’s Medicare Reforms Face Rural Stress Test

A parliamentary committee has launched an inquiry into the rural impacts of changes aimed at strengthening Medicare access and funding. Experts offer mixed reviews.

‘You Aren’t Trapped’: Hundreds of US Nurses Choosing Canada

The relocations are part of a new surge of American nurses, doctors, and other healthcare workers moving to Canada, and specifically British Columbia.

March 4: A Match Deadline Med Students Can’t Miss

The deadline is 9 PM ET Wednesday for fourth-year students to submit their residency preference lists.

Exclusive-South Carolina Seeks Non-CDC Reinforcements to Contain Growing Measles Outbreak

A dozen public health experts are arriving in South Carolina to help the state contain the largest U.S. measles outbreak in more than 30 years, but they're not coming from...

BMI Shapes Oxytocin Needs in Labor Induction

Individuals receiving maximum oxytocin doses have elevated risk for cesarean delivery and postpartum hemorrhage, but the risks are attenuated in those with elevated BMI.

Match Making Made Easy: ‘Take a Deep Breath’

Med students have until March 4 to finalize their Match lists. There is a lot to consider before then.

How These Doctors Fight the Social Media Trust War

As trust in healthcare erodes and disinformation thrives on social media, a small but determined group of physicians wants to win.

FDA Approves New Narcan Packaging, Aiming to Boost Carry Rates

FDA Approves New Narcan Packaging, Aiming to Boost Carry Rates

FDA Approves Tradipitant (NEREUS) for the Prevention of Vomiting Induced by Motion

FDA Approves Tradipitant (NEREUS) for the Prevention of Vomiting Induced by Motion

Increases in Physician Attrition Rates Could Worsen Shortages

Increases in Physician Attrition Rates Could Worsen Shortages

ACP Urges Concern for Health Policy Issues, with Shari Erickson, MPH Shari Erickson, MPH

Erickson discussed key health policy issues the ACP is pushing back against during the organization’s Internal Medicine meeting.

Improving CRC Screening Rates With High-Quality, Noninvasive Tests, with Keith Winfrey, MD, MPH Keith Winfrey, MD, MPH

Winfrey discussed how noninvasive CRC screening tests can help meet gaps when patients face barriers to colonoscopy.

What are the big unanswered questions about cancer? Experts discuss

Over the 40-year history of the University of Colorado Cancer Center, its investigators have answered many questions about cancer—what causes it, how to prevent it, and how to treat it. Those discoveries have helped many ...

Precision therapy could stop breast cancer at the source

Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of ...

Reviving exhausted immune cells boosts tumor elimination

A new study has discovered a molecular signal that tumors exploit to exhaust the T cells meant to destroy them—and how silencing that signal could revive the body's immunity.

Combination immunotherapy for rare cancers shows improved efficacy and survival rates

New results from a multicenter clinical trial show that combining immunotherapy drugs nivolumab and ipilimumab significantly improves treatment response in patients with advanced and difficult-to-treat cancers. The trial ...

Recommended News For You

Lung cancer screening adherence rates decline annually after baseline screening

Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL

Eliminating the SRC-3 gene in immune cells causes an efficient, long-lasting anti-cancer response.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.

In prostate cancer survivorship, sleep disturbances are underappreciated.

Reversing the toxic relationship with high doses of chemotherapy in oncology.

Recommended Articles For You

Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success 

Polyposis Syndrome: Causes, Symptoms, and Treatment Options 

Unlocking the Potential of Trabectedin: A Novel Therapy for Cancer Treatment 

Value, Access, and Affordability in Next-Gen Oncology: Navigating Costs, Coverage, and Clinical Impact 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

2.

investigating radiation oncology applications of artificial general intelligence.

3.

Risk of a second cancer after early breast cancer is low, say new findings

4.

FDA Expands Durvalumab Label to Operable Lung Cancer

5.

Drugmaker Pulls Trodelvy's Bladder Cancer Approval

1.

Oncolytic Adenoviruses Targeting PD-L1: Advancing Cancer Immunotherapy and Tumor Control

2.

A Visual Journey Through Penile Cancer: Examining the Impact of Photos

3.

Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment

4.

Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown

5.

Malignant Prolactinoma: Prolactin Surge with Minimal Growth Masks Widespread Metastases

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias

2.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

3.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

4.

Current Scenario of Cancer- Palliative Care to Close the Care Gap

5.

Navigating the Complexities of Ph Negative ALL - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot